An antibody cocktail called REGN-COV2 designed to treat and prevent coronavirus infection is being tested at FOMAT Medical Research in Oxnard. FOMAT is launching two clinical trials for COVID-19 treatment, the disease caused by the SARS-COV-2, on Thursday, reported CBS Los…
Novavax Secures $1.6 Billion from U.S. Government for COVID-19 Vaccine Program
With rising numbers of COVID-19 infections and as the fight against the novel coronavirus continues, Novavax received $1.6 billion in federal funding to support the clinical development of the company’s vaccine candidate, NVX‑CoV2373. Gaithersburg, Md.-based Novavax said the funding will allow…
Merck, IAVI Work to Develop COVID-19 Vaccine
Merck (NYSE:MRK) and IAVI announced today that they are collaborating to develop an investigational vaccine against SARS-CoV-2 for preventing COVID-19. The vaccine candidate is slated to use the recombinant vesicular stomatitis virus (rVSV) technology used as the basis for Merck’s Ervebo Ebola Zaire virus…
Johnson & Johnson: Clinical study of potential coronavirus vaccine could start by end of year
Johnson & Johnson (NYSE:JNJ) said today that its Janssen Pharmaceutical Cos. has forged a partnership with the Beth Israel Deaconess Medical Center (BIDMC) to support coronavirus vaccine development. Janssen and the virology lab led by Dr. Dan Barouch at BIDMC have…